DSM: Mobilizing the organization to grow through innovation
In February 2009, Rob van Leen, Chief Innovation Officer (CIO) of DSM – a world leader in life sciences and materials sciences – felt his company had made a lot of progress in the way it managed innovation since transforming itself from a commodity chemical company to a high value-added specialty chemical company. However, a lot remained to be done to achieve the ambitious organic growth target of €1 billion through innovation, which was set by top management as part of its “Vision 2010” program. Although management entrusted most of its growth and innovation mission to its business group (BG) directors, it also counted on its high-profile “Corporate Innovation Center,” under van Leen’s leadership, to stimulate, steer and sustain the company’s innovation drive. In the three years since its creation, the Corporate Innovation Center and its various technology and innovation management mechanisms had become operational. But van Leen felt a number of challenges remained: 1) The Innovation Center had been established to create innovative new businesses and help the various BGs achieve functional excellence in innovation. But did it have the right organization and priorities, as well as sufficient resources and competences to do so? 2) In the rather decentralized culture of DSM, how strongly should the CIO push to align the powerful and traditionally independent BGs behind a unified innovation agenda? How could he operate as an effective innovation catalyst without interfering in BG affairs? 3) How could the Innovation Center trigger a deep mindset change towards value creation through customer-centric innovation, in an organizational culture that remained focused on technology push, operational excellence and risk avoidance?
The case addresses the wide range of challenges large companies face when they decide to mobilize their organization to grow through innovation. It describes one approach, i.e. the empowerment of a strong Chief Innovation Officer and setting up a broad range of innovation enhancing activities within a dedicated Innovation Centre. But how to find the appropriate balance between business unit autonomy and a centrally catalyzing innovation function? The case addresses management issues such as having the right organization and setting priorities with sufficient resources and competences to drive an innovation initiative. It discusses what it takes to trigger a deep mindset change towards value creation through customer-centric innovation, in traditionally technology oriented, risk avoiding culture.
2006-2009
Cranfield University
Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Email [email protected]
Harvard Business School Publishing
60 Harvard Way, Boston MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email [email protected]
NUCB Business School
1-3-1 Nishiki Naka
Nagoya Aichi, Japan 460-0003
Tel +81 52 20 38 111
Email [email protected]
IMD retains all proprietary interests in its case studies and notes. Without prior written permission, IMD cases and notes may not be reproduced, used, translated, included in books or other publications, distributed in any form or by any means, stored in a database or in other retrieval systems. For additional copyright information related to case studies, please contact Case Services.
Research Information & Knowledge Hub for additional information on IMD publications
This case series explores Sandoz's spin off from Novartis, which was finalized on 4 October 2023. Case B looks at Sandoz once it has become independent. The hard work of figuring out the best way to spin off is done, a new strategy created, and so...
The Sandoz leadership team faced an important decision as it broke away from Novartis and became a public company. Should Sandoz retain the global geographical coverage it had had in its many years as part of Novartis? Or should it focus on fewer ...
This case series explores Sandoz's spin off from Novartis, which was finalized on 4 October 2023. Case A follows Richard Saynor's (CEO, Sandoz) ruminations as he builds the company strategy in preparation for the board's approval of Sandoz as a st...
Research Information & Knowledge Hub for additional information on IMD publications
in I by IMD
Research Information & Knowledge Hub for additional information on IMD publications
Case reference: IMD-2670 ©2025
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Case reference: IMD-2669 ©2025
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
in I by IMD Brain Circuits 4 September 2025
Research Information & Knowledge Hub for additional information on IMD publications